Profile data is unavailable for this security.
About the company
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Spinach brand offers pre-rolls infused with cold-filtered cannabis extract and coated in kief, and all-in-one disposable vapes. The Lord Jones is a hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions are a line-up of premium ice water hash infused pre-rolls. This brand also offers vapes and edibles. Its PEACE NATURALS offer Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
- Revenue in CAD (TTM)155.68m
- Net income in CAD-66.57m
- Incorporated2020
- Employees626.00
- LocationCronos Group Inc4491 Concession Rd 12TORONTO L0M 1S0CanadaCAN
- Phone+1 (416) 504-0004
- Fax+1 (416) 504-0004
- Websitehttps://thecronosgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torii Pharmaceutical Co Ltd | 529.39m | 47.47m | 1.13bn | 583.00 | 23.20 | 1.02 | 22.02 | 2.13 | 187.71 | 187.71 | 2,093.33 | 4,271.84 | 0.4411 | 2.74 | 2.30 | 100,924,500.00 | 3.96 | 6.52 | 4.39 | 7.35 | 44.46 | 49.55 | 8.97 | 17.98 | 5.19 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Mochida Pharmaceutical Co Ltd | 940.25m | 40.79m | 1.13bn | 1.52k | 26.22 | 0.9199 | 16.89 | 1.20 | 127.75 | 127.75 | 2,945.16 | 3,641.81 | 0.6639 | 1.80 | 3.42 | 68,662,940.00 | 2.88 | 4.37 | 3.41 | 5.31 | 49.61 | 52.47 | 4.34 | 6.71 | 3.50 | -- | 0.00 | 45.16 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
| Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS | 515.87m | 7.30m | 1.14bn | 617.00 | 155.54 | 4.71 | 48.92 | 2.20 | 0.5944 | 0.5944 | 42.00 | 19.62 | 1.68 | 15.72 | 9.78 | 20,256,010.00 | 2.31 | 12.39 | 3.73 | 17.53 | 19.31 | 19.06 | 1.37 | 6.95 | 1.29 | 3.41 | 0.1773 | -- | -23.38 | 47.18 | -28.97 | 147.97 | -- | -- |
| Guizhou Sanli Pharmaceutical Co Ltd | 410.83m | 63.95m | 1.15bn | 2.28k | 18.52 | 3.69 | -- | 2.80 | 0.7798 | 0.7798 | 5.05 | 3.91 | 0.8372 | 2.90 | 4.48 | 925,761.20 | 13.32 | 12.39 | 19.88 | 16.72 | 69.37 | 70.45 | 15.91 | 16.31 | 1.62 | -- | 0.2373 | 25.70 | 36.10 | 17.75 | 45.42 | 21.51 | 127.48 | -- |
| Cronos Group Inc | 155.68m | -66.57m | 1.16bn | 626.00 | -- | 0.7652 | -- | 7.44 | -0.175 | -0.1745 | 0.4068 | 3.96 | 0.0953 | 2.28 | 6.14 | -- | -4.20 | 6.43 | -4.43 | 7.11 | 14.66 | -10.54 | -44.12 | 147.07 | 23.05 | -- | 0.00 | -- | 0.5672 | 48.40 | 54.99 | -- | -50.99 | -- |
| Pliant Therapeutics Inc | 0.00 | -283.54m | 1.18bn | 158.00 | -- | 2.42 | -- | -- | -3.34 | -3.34 | 0.00 | 5.68 | 0.00 | -- | -- | 0.00 | -40.90 | -33.24 | -43.90 | -35.39 | -- | -- | -- | -360.29 | -- | -- | 0.0802 | -- | -83.69 | -- | -30.83 | -- | -16.89 | -- |
| EIS czcbs lc Sn v Fnnsl Ytrmlr Sny v Tcr | 374.73m | 147.36m | 1.19bn | 1.10k | 8.06 | 0.6122 | 6.52 | 3.17 | 5.25 | 5.25 | 13.36 | 69.16 | 0.2227 | 4.12 | 7.88 | 7,999,978.00 | 8.76 | 8.49 | 9.49 | 9.06 | 33.55 | 32.94 | 39.32 | 58.23 | 1.22 | -- | 0.0698 | -- | 86.94 | 56.41 | -8.16 | 62.73 | 141.59 | 31.51 |
| Sihuan Pharmaceutical Holdings Group Ltd | 340.92m | -7.34m | 1.21bn | 2.65k | -- | 1.41 | -- | 3.56 | -0.0044 | -0.0044 | 0.2033 | 0.5102 | 0.1506 | 0.894 | 3.90 | 657,022.90 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
